Pitt Researchers Receive $2.7 Million To Develop Drug That Counters Radiation Exposure
Nov 2nd 2008Drug InformationBio-terrorism
Researchers at the University of Pittsburgh School of Medicine have been awarded $2.7 million from the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS), to develop a radiation mitigator drug that could counter the effects of radiation exposure in case of large-scale public exposure.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
